title: DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
authors.affiliation: Department of Medicine, Huddinge Hospital, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Gahrton
authors.forename: U
authors.initials: U
authors.lastname: Tidefelt
authors.forename: C
authors.initials: C
authors.lastname: Paul
authors.forename: M
authors.initials: M
authors.lastname: Björkholm
authors.forename: G
authors.initials: G
authors.lastname: Grimfors
authors.forename: R
authors.initials: R
authors.lastname: Hast
authors.forename: G
authors.initials: G
authors.lastname: Juliusson
authors.forename: M
authors.initials: M
authors.lastname: Järnmark
authors.forename: A
authors.initials: A
authors.lastname: Killander
authors.forename: E
authors.initials: E
authors.lastname: Kimby
mesh_terms: D000293:Adolescent; D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D004247:DNA / Q000627:therapeutic use*; D018736:DNA Adducts; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D016019:Survival Analysis; D013866:Thioguanine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D018736:DNA Adducts; C031902:doxorubicin-DNA; D000677:Amsacrine; D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D004247:DNA; D011239:Prednisolone; D015122:Mercaptopurine; D013866:Thioguanine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin